Gynecological cancers remain a major threat to women's health, with traditional therapies often having limited effect and ...

One of the oldest challenges in oncology is creating a drug that kills cancer cells while sparing healthy ones. Peptides are ...

MONTREAL, Nov. 13, 2025 /CNW/ - Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendations for the reimbursement of Blenrep (R) (belantamab mafodotin) -- a critical new ...

The Doodle shows how the parabola changes with different numbers, making learning math fun and interactive for students.,, ...

Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - - Sutro has selected PTK7 as the target for ...

Myeloma Canada welcomes the Canadian Drug Agency's (CDA) two positive recommendations for the reimbursement of Blenrep® ...

The market is experiencing dynamic growth, propelled by groundbreaking approvals in neurology and a surge in GLP-1 agonist ...

CytomX Therapeutics, Inc.'s ADC candidate, CX-2051, shows promise in colorectal cancer. Click here to read an analysis of ...

“Our investment in the Durham laboratory services facility reflects Alcami’s dedication to scientific excellence, innovation, and operational agility,” said Katie Schlipp, President of Laboratory ...

To help bridge that gap, Morrisville-based Kymanox Corporation has entered into a non-exclusive collaboration with Jabil Inc., which is based in St. Petersburg, Florida, to support companies ...

Stifel 2025 Healthcare Conference November 11, 2025 10:00 AM ESTCompany ParticipantsOlivier Loeillot - President, CEO ...

This case study demonstrates how advanced NMR spectroscopy enables high-resolution structural characterization of exenatide.